Cargando…

Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer()

Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations and epidermal growth factor receptor (EGFR) family signaling are drivers of tumorigenesis in pancreatic ductal adenocarcinoma (PDAC). Previous studies have demonstrated that combinatorial treatment of PDAC xenografts with the mitogen-activa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindberg, James M., Newhook, Timothy E., Adair, Sara J., Walters, Dustin M., Kim, Alison J., Stelow, Edward B., Parsons, J. Thomas, Bauer, Todd W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198828/
https://www.ncbi.nlm.nih.gov/pubmed/25117978
http://dx.doi.org/10.1016/j.neo.2014.06.004